LY3000328

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3000328, covering 2012-05-31 to 2012-05-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Tolerability of LY3000328 in Healthy Participants [Phase 1]